as on January 17, 2026 at 2:29 am IST
Day's Low
Day's High
1.87%
Downside
3.39%
Upside
52 Week's Low
52 Week's High
60.19%
Downside
20.41%
Upside
Check Vera Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$3.3B
EPS (TTM)
-4.4429
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-269.8M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-73.25%
Compare market cap, revenue, PE, and other key metrics of Vera Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $3.3B | NA | NA | 0.00% | |
| BUY | $47.5B | 115.96% | 1238.83 | 1.36% | |
| BUY | $112.5B | 95.68% | 30.87 | 31.35% | |
| NA | $37.4B | NA | 663.31 | 1.38% | |
| BUY | $78.6B | 41.53% | 17.79 | 32.13% |
The Vera Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vera Therapeutics Inc investment value today
Current value as on today
₹1,44,216
Returns
₹44,216
(+44.22%)
Returns from Vera Therapeutics Inc Stock
₹39,497 (+39.5%)
Dollar Returns*
₹4,720 (+4.72%)
Based on 16 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 16 analysts, 87.5% of analysts recommend a 'BUY' rating for Vera Therapeutics Inc. Average target price of $75.15
Get share price movements and forecasts by analysts on Vera Therapeutics Inc.
What analysts predicted
38.06%UPSIDE
Target Price
$75.15
Current Price
$46.55
Analyzed by
16 Analysts
Target
$75.15
Vera Therapeutics Inc target price $75.15, a slight upside of 38.06% compared to current price of $46.55. According to 16 analysts rating.
Search interest for Vera Therapeutics Inc Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 07 January
Wed, 10:59 PM
-Vera Therapeutics shares rose after FDA accepted atacicept BLA for priority review, targeting IgAN treatment.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 3 months, VERA stock has moved up by 48.9%
Best in 3 Years
![]()
In the last 3 years, VERA has outperformed top 5 stocks with highest market-cap in its industry
Best in 3 Years
![]()
In the last 3 years, VERA has outperformed top 5 stocks with highest market-cap in Textiles & Leather Goods
Best in 1 Year
![]()
In the last 1 year, VERA has outperformed top 5 stocks with highest market-cap in Textiles & Leather Goods
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 61.0% return, outperforming this stock by 21.6%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 31.34% of holdings in Sep 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 68.66% of holdings in Sep 2025 quarter
| Organisation | Vera Therapeutics Inc |
| Headquarters | 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
| Industry | Services |
| CEO | Dr. Marshall W. Fordyce M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. David L. Johnson M.B.A. | Chief Opearating Officer |
Ms. S. Sandra Park J.D. | Senior VP of Legal, Healthcare,Commercial Law, Compliance & Operations |
Ms. Emma Haywood | Vice President of Marketing |
Ms. Julie Person | Chief People Officer |
Dr. Allen Ebens B.Sc., Ph.D. | Executive Vice President of Research |
Ms. Debra Charlesworth | Vice President of Corporate Communications |
Dr. Marshall W. Fordyce M.D. | Founder, President, CEO & Director |
Dr. Robert M. Brenner M.D. | Chief Medical Officer |
Mr. Sean P. Grant M.B.A. | Chief Financial Officer |
Mr. Joseph R. Young M.B.A. | Senior VP of Finance & Chief Accounting Officer |
Vera Therapeutics Inc share price today is $46.55 as on at the close of the market. Vera Therapeutics Inc share today touched a day high of $48.13 and a low of $45.68.
Vera Therapeutics Inc share touched a 52 week high of $56.05 on and a 52 week low of $18.53 on . Vera Therapeutics Inc stock price today i.e. is closed at $46.55,which is 16.95% down from its 52 week high and 151.21% up from its 52 week low.
Vera Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Vera Therapeutics Inc (VERA) shares with as little as ₹90.662 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹906.62 in Vera Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vera Therapeutics Inc share’s latest price of $46.55 as on January 17, 2026 at 2:29 am IST, you will get 0.2148 shares of Vera Therapeutics Inc. Learn more about
fractional shares .